FDA Plays

[volsqueeze]

KERX($4.60) - Upcoming catalysts I gathered from PRs and recent conference calls here:

MAY 2011

Expect Japanese partner to start Phase III program for Zerenex in Japan
Receive $8M milestone payment from the Japanese partner for Zerenex

28 APR 2011

Present full data from the Short-Term Phase III study of Zerenex

End of JUN 2011

Completion of enrollment of patients in the KRX-0401 for the treatment of Multiple Myeloma study
Completion of enrollment of patients in the KRX-0401 for the treatment of Colorectal Cancer study
Completion of enrollment of patients in the Zenerex Long-Term Phase III study

4Q 2011

Expects the event that will trigger the unblinding of the KRX-0401 for the treatment of Colorectal Cancer study to occur
Completion of KRX-0401 for the treatment of Colorectal Cancer study

2Q 2012

Completion of Long-Term Phase III study of Zerenex

2H 2012

Completion of KRX-0401 for the treatment of Multiple Myeloma

Mid-2012

Commercialization of KRX-0401 for the treatment of Colorectal Cancer study

3Q 2012

NDA filing for Zerenex